Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis

We investigated the serum concentrations of interleukin-6 (IL-6) and two IL-6 family of cytokines (leukaemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) as well as IL-6 soluble receptor (sIL-6R) using an enzyme-linked immunosorbent assay (ELISA) in 66 patients with rheumatoid arth...

Full description

Saved in:
Bibliographic Details
Main Authors: T. Robak, A. Gladalska, H. Stepień, E. Robak
Format: Article
Language:English
Published: Wiley 1998-01-01
Series:Mediators of Inflammation
Subjects:
Online Access:http://dx.doi.org/10.1080/09629359890875
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563647200624640
author T. Robak
A. Gladalska
H. Stepień
E. Robak
author_facet T. Robak
A. Gladalska
H. Stepień
E. Robak
author_sort T. Robak
collection DOAJ
description We investigated the serum concentrations of interleukin-6 (IL-6) and two IL-6 family of cytokines (leukaemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) as well as IL-6 soluble receptor (sIL-6R) using an enzyme-linked immunosorbent assay (ELISA) in 66 patients with rheumatoid arthritis (RA) and 24 healthy controls. We examined a possible association between the serum levels of these peptides and RA activity according to the Mallya and Mace scoring system and Ritchie's index. We also evaluated the correlation between the serum levels of IL-6, LIF, CNTF and sIL-6R and duration of the disease and calculated sIL-6R/IL-6 ratio in RA patients and in the control group. IL-6 and sIL-6R were detectable in all 66 patients with RA and 24 normal individuals. LIF was also found in the serum of all patients with RA and in 16 (66.7%) normal individuals. In contrast CNTF was measurable only in 15 (22.7%) patients with RA and 24 (33.3%) normal individuals. The highest IL-6 and sIL-6R levels were found in the patients with Stages 3 and 4 of RA activity and the lowest in the control group. In contrast there were no statistically significant diferences between the LIF and CNTF levels in RA patients and normal individuals. We found positive correlation between IL-6 and sIL-6R concentrations and Ritchie's index and a lack of such correlation with LIF and CNTF. IL-6 serum level correlated positively with the disease duration, but sIL-6R, LIF and CNTF did not. Serum sIL-6R/IL-6 ratio was significantly lower in RA patients than in healthy controls. In conclusion, an increase in the serum levels of IL-6 and sIL-6R, but not LIF and CNTF concentrations, may be useful markers for RA activity.
format Article
id doaj-art-8dffdb89e5b44d7d83ecdaea4b8ae78b
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 1998-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-8dffdb89e5b44d7d83ecdaea4b8ae78b2025-02-03T01:12:58ZengWileyMediators of Inflammation0962-93511466-18611998-01-017534735310.1080/09629359890875Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritisT. Robak0A. Gladalska1H. Stepień2E. Robak3Institute of Internal Medicine, Medical University of Lódź, Copernicus Hospital, Pabianicka 62, Lódź Rheumatology Unit, PolandRheumatology Unit, City Hospital, Prymasa Wyszyńskiego 14, Radomsko, 97–500, PolandDepartment of Experimental Endocrinology, Medical University of Lódź, Sterlinga 5, Lódź 91–425, PolandDepartment of Dermatology, Medical University of Lódź, Krzemieniecka 6, Lódź 94–017, PolandWe investigated the serum concentrations of interleukin-6 (IL-6) and two IL-6 family of cytokines (leukaemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) as well as IL-6 soluble receptor (sIL-6R) using an enzyme-linked immunosorbent assay (ELISA) in 66 patients with rheumatoid arthritis (RA) and 24 healthy controls. We examined a possible association between the serum levels of these peptides and RA activity according to the Mallya and Mace scoring system and Ritchie's index. We also evaluated the correlation between the serum levels of IL-6, LIF, CNTF and sIL-6R and duration of the disease and calculated sIL-6R/IL-6 ratio in RA patients and in the control group. IL-6 and sIL-6R were detectable in all 66 patients with RA and 24 normal individuals. LIF was also found in the serum of all patients with RA and in 16 (66.7%) normal individuals. In contrast CNTF was measurable only in 15 (22.7%) patients with RA and 24 (33.3%) normal individuals. The highest IL-6 and sIL-6R levels were found in the patients with Stages 3 and 4 of RA activity and the lowest in the control group. In contrast there were no statistically significant diferences between the LIF and CNTF levels in RA patients and normal individuals. We found positive correlation between IL-6 and sIL-6R concentrations and Ritchie's index and a lack of such correlation with LIF and CNTF. IL-6 serum level correlated positively with the disease duration, but sIL-6R, LIF and CNTF did not. Serum sIL-6R/IL-6 ratio was significantly lower in RA patients than in healthy controls. In conclusion, an increase in the serum levels of IL-6 and sIL-6R, but not LIF and CNTF concentrations, may be useful markers for RA activity.http://dx.doi.org/10.1080/09629359890875Interleukin 6Leukaemia inhibitory factorCilary neurotrophic factorSoluble inte rleukin 6 receptorRheumatoid arthritisDisease activity.
spellingShingle T. Robak
A. Gladalska
H. Stepień
E. Robak
Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
Mediators of Inflammation
Interleukin 6
Leukaemia inhibitory factor
Cilary neurotrophic factor
Soluble inte rleukin 6 receptor
Rheumatoid arthritis
Disease activity.
title Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
title_full Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
title_fullStr Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
title_full_unstemmed Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
title_short Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
title_sort serum levels of interleukin 6 type cytokines and soluble interleukin 6 receptor in patients with rheumatoid arthritis
topic Interleukin 6
Leukaemia inhibitory factor
Cilary neurotrophic factor
Soluble inte rleukin 6 receptor
Rheumatoid arthritis
Disease activity.
url http://dx.doi.org/10.1080/09629359890875
work_keys_str_mv AT trobak serumlevelsofinterleukin6typecytokinesandsolubleinterleukin6receptorinpatientswithrheumatoidarthritis
AT agladalska serumlevelsofinterleukin6typecytokinesandsolubleinterleukin6receptorinpatientswithrheumatoidarthritis
AT hstepien serumlevelsofinterleukin6typecytokinesandsolubleinterleukin6receptorinpatientswithrheumatoidarthritis
AT erobak serumlevelsofinterleukin6typecytokinesandsolubleinterleukin6receptorinpatientswithrheumatoidarthritis